Autoimmune Research
McGill describes gene in 20% of people of African descent that shuts down immune system
Published in Gene Therapy Weekly, May 18th, 2006
In a groundbreaking new study published recently in Nature, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages, allowing researchers to develop methods to counter its damaging effects.
Caspase-12 is found in around 20% of people of African descent, but was entirely lost from all other ethnicities around 60,000 years ago. "It's a mystery why only African populations retained this enzyme," said Dr. Maya Saleh, a medical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-05-18)
More Articles from Gene Therapy Weekly
- Bloom Syndrome
Bloom syndrome gene expression silenced in human cells by gene targeting - Diabetes Gene Therapy
Type 1 diabetes genetic susceptibility is demonstrated by in vivo RNA interference - Epstein-Barr Virus
EBV antigens are re-targeted by T cells following TCR gene transfer - Gene Research
Mouse study reveals human gene therapy may pose substantial cancer risk - Neuroscience
Learning is impaired by NMDAR1 subunit knock-down in hippocampal neurons - Accreditation
CombiMatrix Molecular Diagnostics receives accreditation from CAP - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
